The SLC22A6 gene helps kidney cells move certain medicines, body chemicals, and waste products from the blood so they can leave the body in urine. If it does not work as expected, your body may clear some drugs and natural waste products less efficiently. What this gene does can influence how your body responds to medications, so changes in the SLC22A6 gene are mainly studied for their effects on drug handling and kidney transport.
What is a gene?
Genes are stretches of DNA that hold instructions your cells use to make molecules or manage processes throughout the body. Some provide the directions for producing proteins, which are the working parts of cells. Others mostly guide when, where, and how much certain processes occur. Taken together, genes affect how the body grows and works, and they can influence how you respond to food, stress, or medications. More detail on this topic is available in the LearnHub.
Overview
SLC22A6Gene function
What if the gene works
The SLC22A6 gene helps kidney cells move waste products, medicines, and other small charged substances from blood into urine. This supports the body’s routine clearing of chemicals and helps keep blood chemistry balanced.
Risk
What if the gene does not work
Variants in the SLC22A6 gene can reduce or block a kidney transporter that moves organic acids from blood into kidney tubule cells. Milder variants may partly lower transport, while more severe variants can cause near-complete loss.
Treatment
What does that mean for your treatment
No SLC22A6-specific treatment or management approach is currently established for people with a pathogenic or loss of function variant in the SLC22A6 gene. The SLC22A6 gene is being studied as a kidney drug transporter that may help explain how some medicines are cleared and why certain drug interactions affect the kidneys.
Gene function
What if the gene works
Your kidneys depend on the SLC22A6 gene to move certain small molecules out of the blood and into kidney tubule cells. This supports the steady clearing work your kidneys do all day. Its protein is part of the transport system that helps prepare body made compounds and some medicines for removal in urine.
The SLC22A6 gene helps kidney tubule cells take up many negatively charged small molecules from the bloodstream. This is the first step in moving these substances toward the urine for normal clearance.
Its protein moves body made compounds, including natural waste products and signaling chemicals, into kidney cells. This supports everyday kidney filtering and is a central part of SLC22A6 gene function in the kidney.
The transporter also recognizes many medicines and other foreign compounds in the blood. By bringing them into kidney tubule cells, it helps the body get them ready for removal in urine.
By moving these compounds into kidney cells, this transporter helps control which small molecules stay in the blood and which are passed into urine. That supports steady day to day balance in the body.
What is a variant?
A genetic variant is a small difference in the DNA sequence within a gene. These changes are common and help shape normal human diversity, including differences in appearance, metabolism, and how the body responds to environmental influences. Many variants do not have any noticeable effect and are simply part of natural genetic variation. In some situations, however, a variant can change how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the SLC22A6 gene can change how well kidney cells move certain waste products and medicines across their membranes. Some alter the transporter’s shape, making it less stable, less able to reach the cell surface, or less efficient at binding and moving organic anions. This helps explain how SLC22A6 gene variants affect kidney drug transport. Milder changes may reduce activity only for some compounds, while more severe variants can sharply lower or nearly eliminate transport.
How variants are linked to conditions
At present, the SLC22A6 gene does not yet have a broadly confirmed link to a specific health condition, although research continues to refine how SLC22A6 gene variants are linked to conditions. If you have a confirmed variant in the SLC22A6 gene, your doctor or genetic counselor can interpret it in the context of your health and family history.
A variant is not necessarily a diagnosis
Genetic variants are a routine part of human biology and are widely found across the general population. Most do not directly affect health and simply reflect natural variation among people. For many genes, having a variant associated with a condition points to a possible link rather than a certain diagnosis, particularly when several genes and environmental influences play a role. In some situations, though, one well-characterized variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce health risk related to the SLC22A6 gene itself. If a change in SLC22A6 is found on testing, a doctor or genetic counselor can help explain what it may mean in the context of your overall health and medicines.
Inheritance of SLC22A6 variants
There is not yet a broadly confirmed Mendelian inheritance pattern tied to a specific SLC22A6-related condition. In practice, how variants of the SLC22A6 gene are inherited has not been linked to one well-established autosomal dominant, autosomal recessive, or X-linked disease pattern. The SLC22A6 gene is located on chromosome 11, which is an autosome, so you inherit one copy from each parent.
What does my SLC22A6 result mean for my family?
There is not yet a broadly confirmed inherited condition linked to the SLC22A6 gene in the way seen for some other genes. If you have a specific SLC22A6 result and want to know whether it could matter for relatives, a doctor or genetic counselor can explain what it may mean in the context of your personal and family history.
Genetic information
Genetic testing
How you find out about variants
To learn how genetic testing finds SLC22A6 variants, a lab usually analyzes DNA from a blood or saliva sample, reads the SLC22A6 gene, and compares it with a reference sequence. Results may show a variant, no variant, or a finding whose meaning is still being clarified.
When should I consider getting a genetic test?
There is not yet a broadly established reason to get genetic testing just for the SLC22A6 gene. Testing decisions are usually based on your overall health, medicines, and family history, and are best discussed with a doctor or genetic counselor.
A genetic result is only one part of your health story
A genetic result can provide useful insight, but what it can tell you varies with the condition and the kind of variant found. Over time, many factors, including lifestyle, environment, age, and medical history, affect how the body functions. In some conditions, particularly those shaped by many genes, genetic information offers context rather than certainty and makes the most sense when considered with other parts of care. In other situations, it may give a clear answer. In areas like medication response, genetic results can also help frame individual experiences.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in DNA can change how the body absorbs, moves, breaks down, or clears a drug, so the same treatment may work better for one person than for another. These differences are common and can influence how much benefit someone gets from a medicine or how sensitive they are to side effects.
What is Pharmacogenetics?
Pharmacogenetics examines how differences in genes shape medication response. It studies the relationship between genes and drugs to help explain why the same treatment works differently from one person to another. For many medicines, genes influence how strongly a drug works or how the body handles it. This information can support more informed, more individualized treatment decisions. You can read more about this topic in the LearnHub.
Drugs influenced by the SLC22A6 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medicine choices, so questions about side effects, kidney health, or how well a treatment is working are best discussed with your doctor. Researchers have studied the SLC22A6 gene because it helps the kidneys move some medicines, including some antiviral and antibiotic drugs, but this has not become part of routine prescribing.
History
Researchers identified the SLC22A6 gene in the 1990s during work on how the kidneys move waste products and medicines out of the blood. It was recognized as part of a broader family of transport genes that helped explain why some compounds are cleared into urine so efficiently. Building on this early work, scientists linked the SLC22A6 gene to the transporter often called OAT1, which became important in studies of kidney physiology and drug handling. Later research placed this gene on chromosome 11 and clarified its close relationship to similar transport genes nearby. Its history is mostly tied to steady advances in kidney and medication research rather than a single high profile public event.